A 2015 study in the journal PLOS Biology estimated that $28 billion is spent annually in the U.S. on preclinical research that is not reproducible.
One reason for what some researchers have called a “crisis” in reproducibility is that in certain types of laboratories, some scientists still track their day-to-day research activities in paper notebooks—or, worse yet, in their heads. That’s according to Scott Fulton, CEO of Madison, WI-based Cellara. The startup is developing software designed for researchers in stem cell labs that it says can improve reproducibility of experiments and collaboration among groups around the world.
Formed in 2012, Cellara has been working with several organizations in Wisconsin to develop and test its digital tools. The company plans to formally launch its CultureTrax software to the market later this month in Boston at the annual meeting of the International Society for Stem Cell Research. Read the full story here.